Detection of the off-target effects of base editors is important for identifying their safety risks but current methods for understanding their global activities have limitations in terms of ...
CRISPR–Cas9 is a powerful genome-editing tool 1, but genome-wide off-target activity can hinder therapeutic applications. Negative supercoiling ((−)SC) has been implicated in off-target activity, but ...